From: 19/05/2016 to: 20/05/2016 ESO,CNIO and NRCO Conference on Familial Cancer, Madrid, Spain                                        From: 20/05/2016 to: 25/05/2016 3rd ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Bratislava, Slovak Republic                                        From: 10/06/2016 to: 14/06/2016 2nd Masterclass on Systematic Reviews in Cancer Care, Guidelines and Research, Belfast, United Kigdom                                        From: 11/06/2016 to: 16/06/2016 6th ESO-SIOP Europe Masterclass in Paediatric Oncology, Berlin, Germany                                        From: 17/06/2016 to: 18/06/2016 ESGO-ENYGO-ESO Masterclass in Gynaecological Oncology, Lund, Sweden                                        From: 24/06/2016 to: 26/06/2016 2nd Masterclass on Cancer Patient Advocacy, Milan, Italy                                        From: 29/06/2016 to: 29/06/2016 13th ESO Colorectal Cancer Observatory, Barcelona, Spain                                        From: 04/07/2016 to: 05/07/2016 ESMO Preceptorship on Immuno-Oncology 2016, Siena, Italy                                        From: 14/07/2016 to: 19/07/2016 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 29/08/2016 to: 09/09/2016 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Poznan, Poland                                        From: 15/09/2016 to: 16/09/2016 Eastern Europe and Balkan Region Refresher Course on Gastro-intestinal Cancer, Budapest, Hungary                                        From: 15/09/2016 to: 17/09/2016 ESO-EANO Masterclass in Neuro-Oncology: A Challenges in Radiotherapy for Patients with Gliomas, Lugano, Switzerland                                        From: 30/09/2016 to: 01/10/2016 ESMO Preceptorship on Immuno-Oncology 2016, Amsterdam, The Netherlands                                        From: 19/10/2016 to: 19/10/2016 Multidisciplinary Care in Prostate Cancer Units: A European Guidelines and Beyond, Dublin, Ireland                                        From: 28/10/2016 to: 30/10/2016 5th ESO Arab Countries Masterclass in Clinical Oncology, Cairo, Egypt                                        From: 02/11/2016 to: 03/11/2016 ESMO Preceptorship on Immuno-Oncology 2016, Zurich, Switzerland                                        From: 10/11/2016 to: 12/11/2016 3rd ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland                                        From: 23/11/2016 to: 24/11/2016 ESO Course on Gynecological and Urogenital Tumours, Tbilisi, Georgia                                        From: 18/11/2016 to: 19/11/2016 ESNM-ESO Learning Course on 18FDG PET-CT in Lymphoma, Vienna, Austria                                        From: 19/11/2016 to: 23/11/2016 4th ESO-ESTRO Masterclass in Radiation Oncology, Prague, Czech Republic                                        From: 23/11/2016 to: 24/11/2016 ESO-TUM-IAS Masterclass in Ethical Counselling in Oncology and Gender Issues, Munich, Germany                                        From: 25/11/2016 to: 26/11/2016 Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology, Rome, Italy                                        From: 25/11/2016 to: 27/11/2016 Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 09/11/2016 to: 10/11/2016 ESMO Preceptorship on Immuno-Oncology 2016, Madrid, Spain

In collaboration with

             Media partner:


Held under the patronage of

And with the support of


Programme Structure

23 October 2014

21:00 What we want to achieve in this WOF
A. Eggermont

24 October 2014
F. Cavalli

Chairperson: PG. Pelicci, IEO Milan

 Challenges and opportunities for translating basic cancer research into new treatments
P. Workman, The Institute of Cancer Research, London


 Coffee break

Chairperson: Richard Schilsky, American Society of Clinical Oncology, USA

 11:15 The new role of immunotherapy in cancer treatment
L. Zitvogel, Gustave Roussy Cancer Campus Grand Paris, Paris

 12:00 Discussion



 14:30 Short Presentation

Initiative for providing anti-cancer drugs to Eastern Europe
M. Piccart, Brussels

 14:45 Short Presentation

Global taskforce on radiotherapy for cancer control (GTFRCC)
M. Gospodarowicz, Toronto

Chairperson: A. Eggermont, Gustave Roussy Cancer Campus Grand Paris, Paris

15:30 How to evaluate the utility of cancer treatment
M. Rawlins, NICE, London

 16:15 Discussion

 Coffee break

 17:30 General discussion

 19:00 Close
25 October 2014 
Chairperson: C. Wild, IARC, Lyon

 Efficacious and affordable treatments in the developing countries
R. Sankaranarayanan, IARC, Lyon

 10:00 Short Presentation

Update on Global Taskforce on Expanded Access to Cancer Care and Control
M. Gospodarowicz, Toronto

 10:15 Surgery in low and middle income countries
R. Sullivan, UK

 10:30 Coffee break

 10:45 Final discussion 
F. Cavalli and A. Eggermont

 Most of the speaker's presentation slides are available here
 Please, be aware that the slides are restricted to ClubESO members only.
 We invite you to subscribe (free-of-charge) to ClubESO here


Please, click here to view the video.


Fifty experts were invited to attend the 2014 meeting and contribute to the discussion. Participants were selected based on the following criteria:


 Leading cancer clinicians and researchers who have partially or already participated in the first edition of WOF, with the addition of new experts related to the topic to be discussed.

 Leaders who represent important international organizations.

Matti Aapro, Clinique de Genolier, Switzerland
Andree Blaukat, Merck Serono, Germany
Christopher Booth, Queen’s University, Canada
Riccardo Braglia, Helsinn, Switerland
Otis Brawley, American Cancer Society, USA
Franco Cavalli, European School of Oncology, Switzerland
Eduardo Cazap, Latin-American & Caribbean Society of Medical Oncology (SLACOM), Argentina
Thomas Cerny, HCARE-KSSG-ONKO, Switzerland
Alberto Costa, European School of Oncology, Italy and Switzerland
Alexander M.M. Eggermont, Gustave Roussy Cancer Campus Grand Paris, France
Nelly Enwerem-Bromson, IAEA, Austria
Mary Gospodarowicz, Princess Margaret Cancer Centre, Canada
Axel Hanauske, Lilly Deutschland GmbH, Germany
Augustin Lage, Center of Molecular Immunology (CIM), Cuba
Jonathan Licht, Northwestern University, USA
Ian Magrath, International Network for Cancer, Belgium
Alex Matter, Experimental Therapeutic Centre & D3, A*STAR, Singapore
Rene Medema, Netherlands Cancer Institute, The Netherlands
Hitoshi Nakagama, National Cancer Center Research Institute, Japan
Douglas Noonan, Università degli Studi dell’Insubria, Italy
Jakob Passweg
, Universitätspital Basel, Switzerland
Pier Giuseppe Pelicci, European Institute of Oncology, Italy
Martine Piccart, Institute Jules Bordet, Belgium
Bob Pinedo, VU Medical Center/Fundashon Prevenshon, The Netherlands/Curacao
Michael Rawlins, UK
Rengaswamy Sankaranarayanan, International Agency for Research on Cancer (IARC), France
Luiz Santini, INCA – Brazilian National Cancer Institute, Brazil
Richard Schilsky, American Society of Clinical Oncology, USA
Steve Shak, Genomic Health, USA
Andreas Ullrich, World Health Organization, Switzerland
Chris Wild, International Agency for Research of Cancer (IARC), France
Paul Workman, The Institute of Cancer Research, UK
Laurence Zitvogel, Gustav Roussy Cancer Campus Grand Paris, France
Walter Zoss, Network of National  Cancer Institutes of the Union of the South American Nations, Brazil

ESO Observers
Andrea Decensi, E. O. Espedali Galliera, Italy
Olivia Pagani, Oncology Institute of Southern Switzerland, Switzerland
Anna Wagstaff, Cancer World Magazine, UK

Media Partners

WOF 2014 was again organized in conjunction with Cancer World  (, which explores the world of European cancer care from the perspective of the clinician, the researcher, the administrator and the patient. The magazine gives a voice to health professionals in all fields and at all levels, and offers a platform to those who are most affected by cancer - the people with the disease.

The exclusive scientific media partner for WOF 2014 was again The Lancet. We are very proud of this partnership since The Lancet is by far the most authoritative scientific journal in its field printed in Europe and will provide greater visibility to WOF. In 2012 The Lancet published, on at least two occasions, editorials and commentaries about WOF while the three keynote lectures were published as complete papers in the December 16, 2013 online issue and will be published in print in early 2014.


On the occasion of the 30th anniversary of ESO, the first edition of the World Oncology Forum was organised in Lugano at the end October 2012 (link a WOF 2012).  100 invited experts, including almost 20 scientific journalists from the lay as well as from the scientific press, discussed during two days the question: “Are we winning the war against cancer?” 


The meeting was organised with the scientific collaboration of The Lancet, whose Editor-in-Chief R. Horton led the final discussion which resulted in the formulation of the Appeal “Stop Cancer Now!”. This Appeal was then published as a full page advertisement on 4th February 2013 (World Cancer Day) in the corresponding languages of five leading global newspapers: the International Herald Tribune, Le Monde, El Pais, Neuer Zurcher Zeitung, La Repubblica. WOF 2014 and the Appeal also appeared as the subject of a feature piece in Cancer World.

      The Stop Cancer Now! appeal is available as a pdf in:


Mandarin Chinese 

That same week, The Lancet published not only the Appeal, but also an editorial and a commentary on the WOF:

Stop Cancer Now!

An appeal to world leaders: stop cancer now!
Franco Cavalli

On 16 December 2013, the three WOF-related papers were published:

Global cancer patterns: causes and prevention
Paolo Vineis, Christopher P. Wild

Rethinking the war on cancer
Douglas Hanahan

Cancer survival: global surveillance will stimulate health policy and improve equity
Michel P. Coleman